Effects of Guanfacine Extended-Release on ADHD Symptoms and BMI in Children: A Clinical Comparison Study

This clinical survey compared ADHD children receiving guanfacine extended-release monotherapy versus non-pharmacological treatment alone, measuring changes in BMI and ADHD symptoms over approximately 2 years. Guanfacine significantly improved ADHD Rating Scale scores without causing weight gain, though both treatment groups showed modest increases in high BMI prevalence.